Literature DB >> 32936845

PURL: Is it better to take that antihypertensive at night?

Michael Dickman1.   

Abstract

A large RCT in a primary care setting comparing bedtime to upon-waking administration of antihypertensives answers the question.

Entities:  

Year:  2020        PMID： 32936845      PMCID： PMC7536099     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  9 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

3.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

Review 4.  Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

5.  Hypertension Awareness, Treatment, and Control in US Adults: Trends in the Hypertension Control Cascade by Population Subgroup (National Health and Nutrition Examination Survey, 1999-2016).

Authors:  Kathryn Foti; Dan Wang; Lawrence J Appel; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

6.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

7.  Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.

Authors:  Ramón C Hermida; Juan J Crespo; Manuel Domínguez-Sardiña; Alfonso Otero; Ana Moyá; María T Ríos; Elvira Sineiro; María C Castiñeira; Pedro A Callejas; Lorenzo Pousa; José L Salgado; Carmen Durán; Juan J Sánchez; José R Fernández; Artemio Mojón; Diana E Ayala
Journal:  Eur Heart J       Date:  2020-12-21       Impact factor: 29.983

Review 8.  Evening versus morning dosing regimen drug therapy for hypertension.

Authors:  Ping Zhao; Ping Xu; Chaomin Wan; Zhengrong Wang
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

9.  Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline.

Authors:  Kirsten S Dorans; Katherine T Mills; Yang Liu; Jiang He
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.